Treatment of Rare Neurological Diseases – Dx3 2016 Tech Spotlight

November 10, 2016 Kenny Zamora

nhtherapeutics

NHTherapeutics Inc. (NHT) is a biopharmaceutical company, based in Toronto, that has a specific focus on the development of compounds that target neurological disorders. Amber Mac chats with Aldemar De Groot, CEO, about why NHT decided to have Canada as the place to officially launch this type of business.

Previous Article
The Intrapreneur Alliance Meetup #1: The User. The Business. The Competition. The Technology.
The Intrapreneur Alliance Meetup #1: The User. The Business. The Competition. The Technology.

Providing a roadmap for Intrapreneurial Success through deconstructing the user, business, competitive and ...

Next Article
What Netflix Can Teach Us About Original Content
What Netflix Can Teach Us About Original Content

Ask anyone to name three TV shows that they’re eagerly anticipating in the next year, and all three of thos...

Get the latest Dx3 news delivered to your inbox!

Sign Up